These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24676719)

  • 1. Circulating anti-BP180 NC16a and anti-BP230 autoantibodies in patients with genital lichen sclerosus do not correlate with disease activity and pruritus.
    Patsatsi A; Kyriakou A; Mantas A; Vavilis D; Patsialas C; Sotiriadis D
    Acta Derm Venereol; 2014 Nov; 94(6):711-2. PubMed ID: 24676719
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of circulating anti-bullous pemphigoid antibodies in patients with lichen sclerosus.
    Gambichler T; Höxtermann S; Skrygan M; Eberz B; Regauer S; Scola N; Kreuter A
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):369-70. PubMed ID: 20524944
    [No Abstract]   [Full Text] [Related]  

  • 4. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses.
    Feliciani C; Caldarola G; Kneisel A; Podstawa E; Pfütze M; Pfützner W; Hertl M
    Br J Dermatol; 2009 Aug; 161(2):306-12. PubMed ID: 19485996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
    Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P
    Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
    Nagamoto E; Fujisawa A; Jinnin M; Koga H; Ishii N; Hashimoto T; Yoshino Y
    J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
    [No Abstract]   [Full Text] [Related]  

  • 7. BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?
    Schmidt T; Sitaru C; Amber K; Hertl M
    Br J Dermatol; 2014 Aug; 171(2):212-9. PubMed ID: 24601973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid.
    Tampoia M; Lattanzi V; Zucano A; Villalta D; Filotico R; Fontana A; Vena GA; Di Serio F
    Ann N Y Acad Sci; 2009 Sep; 1173():15-20. PubMed ID: 19758126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses.
    Fania L; Caldarola G; Müller R; Brandt O; Pellicano R; Feliciani C; Hertl M
    Clin Immunol; 2012 Jun; 143(3):236-45. PubMed ID: 22534318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva.
    Howard A; Dean D; Cooper S; Kirtshig G; Wojnarowska F
    Australas J Dermatol; 2004 Feb; 45(1):12-5. PubMed ID: 14961902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
    Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
    Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients.
    Ingen-Housz-Oro S; Plée J; Belmondo T; Maizières M; Pham BN; Hüe S; Ortonne N; Durlach A; Wolkenstein P; Chosidow O; Bernard P
    Dermatology; 2015; 231(1):50-5. PubMed ID: 25871736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
    Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
    Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid.
    Patsatsi A; Kyriakou A; Pavlitou-Tsiontsi A; Giannakou A; Sotiriadis D
    Clin Dev Immunol; 2012; 2012():854795. PubMed ID: 23227089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
    Chan LS
    Arch Dermatol; 2011 Mar; 147(3):291-2. PubMed ID: 21422335
    [No Abstract]   [Full Text] [Related]  

  • 16. Scarring autoimmune bullous disease in a Ugandan patient with autoantibodies to BP180, BP230, and laminin 5.
    Mulyowa GK; Jaeger G; Sitaru C; Bröcker EB; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S43-6. PubMed ID: 16427991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of pemphigoid gestationis with concurrent IgG antibodies to BP180, BP230 and type VII collagen.
    Yang B; Wang C; Wu M; Du D; Yan X; Zhou G; Zhang F
    Australas J Dermatol; 2014 Feb; 55(1):e15-8. PubMed ID: 23082779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
    Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
    Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study.
    Fichel F; Barbe C; Joly P; Bedane C; Vabres P; Truchetet F; Aubin F; Michel C; Jegou J; Grange F; Antonicelli F; Bernard P
    JAMA Dermatol; 2014 Jan; 150(1):25-33. PubMed ID: 24226428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid.
    Esmaili N; Mortazavi H; Kamyab-Hesari K; Aghazadeh N; Daneshpazhooh M; Khani S; Chams-Davatchi C
    Clin Exp Dermatol; 2015 Apr; 40(3):324-30. PubMed ID: 25476471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.